Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

EULAR 2024 New Gout Drugs Might Increase Patients at Target Urate Level New options in late stages of clinical testing for refractory gout promise to increase the chances of reaching the guideline ...

It has been awarded a fast-track review by the FDA, which Sobi said “underscores the urgent need for new treatment options for patients with chronic refractory gout.” If approved, it will ...

Gout has often been seen as a consequence of lifestyle choices, but new research is rewriting this narrative. An ...

Scientists from the University of California San Diego have uncovered a new cause of gout that could lead to more effective ...

Good news for people with diabetes who can enjoy better kidney health as well as ward off gout, thanks to a pioneering ...

Discover the causes, symptoms, and treatment options for gout—a painful form of arthritis predominantly affecting men.

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from Canada ...

Sodium glucose cotransporter 2 inhibitors used to treat diabetes may also reduce the risk of recurrent kidney stones and gout ...

In fact, existing drugs could be repurposed for ... treatments will become available with the new targets we identified," says Merriman. "Gout deserves more health spend resource and greater ...

Gout causes sudden flares of joint pain, which often arise during the nighttime, and in the big toe, though it may affect other joints including the ankles | Genetics And Genomics ...

After one to two weeks, the inflammation eventually goes away on its own. If you have gout, talk to your doctor about medications and lifestyle changes that can help.